Publication:
Pulmonary Vasculitis in Behçet Disease: A Cumulative Analysis

dc.authorscopusid35582867600
dc.authorscopusid7004571672
dc.authorscopusid6602346481
dc.contributor.authorUzun, O.
dc.contributor.authorAkpolat, T.
dc.contributor.authorErkan, L.
dc.date.accessioned2020-06-21T15:36:52Z
dc.date.available2020-06-21T15:36:52Z
dc.date.issued2005
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Uzun] Oǧuz, Department of Pulmonary Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey, 19 Mayis Universitesi, Kurupelit, Samsun, Turkey; [Akpolat] Tekin, Department of Internal Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Erkan] Levent, Department of Pulmonary Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractStudy objectives: The aims of this study were to investigate the frequency of pulmonary problems in Behçet disease (BD), and to discuss lesser-known features of pulmonary BD such as clinical characteristics, analysis of prognosis, and evaluation of treatment options with respect to the previously published cases. Design: We conducted a comprehensive review of the literature to analyze cumulated data about pulmonary involvement in BD. Setting: We found 159 articles regarding pulmonary disease associated with BD in May 2003. Patients: The evaluation of these articles demonstrated 598 pulmonary problems in 585 cases. Results: Pulmonary artery aneurysms (PAAs) are the most common pulmonary lesion in BD, and these are almost always associated with hemoptysis. Seventy-eight percent of patients with aneurysms have concomitant extrapulmonary venous thrombi or thrombophlebitis. Other pulmonary problems are reported in BD, and these are principally related to vascular lesions and radiologic abnormalities. Conclusions: Pulmonary vascular problems, either PAA or involvement of small-sized vessels, are the main pulmonary disorders in BD. Immunopathologic findings indicate that the underlying pathogenesis is pulmonary vasculitis, which may result in thrombosis, infarction, hemorrhage, and PAA formation. Patients with small nonspecific radiologic abnormalities should be followed up closely since early diagnosis of vascular lesions may be life-saving. Immunosuppression is the main therapy for the treatment of a vasculitis. It is important that pulmonary angiitis is not mistaken for pulmonary thromboembolic disease since fatalities have occurred in BD shortly after initiation of anticoagulation/thrombolytic treatment.en_US
dc.identifier.doi10.1378/chest.127.6.2243
dc.identifier.endpage2253en_US
dc.identifier.issn0012-3692
dc.identifier.issn1931-3543
dc.identifier.issue6en_US
dc.identifier.pmid15947344
dc.identifier.scopus2-s2.0-21844465661
dc.identifier.scopusqualityQ1
dc.identifier.startpage2243en_US
dc.identifier.urihttps://doi.org/10.1378/chest.127.6.2243
dc.identifier.volume127en_US
dc.identifier.wosWOS:000229767300056
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherAmerican College of Chest Physiciansen_US
dc.relation.ispartofChesten_US
dc.relation.journalChesten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnticoagulationen_US
dc.subjectBehçet Diseaseen_US
dc.subjectImmunosuppressionen_US
dc.subjectPulmonary Artery Aneurysmen_US
dc.subjectPulmonary Thromboembolic Diseaseen_US
dc.subjectVasculitisen_US
dc.titlePulmonary Vasculitis in Behçet Disease: A Cumulative Analysisen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files